Catheter-Directed Thrombolysis Devices Market 2023-2028 | Trends, Report, Industry Growth, Research Analysis

The latest research study “Catheter-Directed Thrombolysis Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” by IMARC Group, finds that the global catheter-directed thrombolysis devices market size reached US$ 356.7 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 489.0 Million by 2028, exhibiting a growth rate (CAGR) of 5.5% during 2023-2028.

Download a Free PDF Sample for more detailed market insights:

Thrombolysis is the therapeutic process of treating blood clots and improving blood flow by preventing the damage of tissue and organs. Catheter-directed thrombolysis devices help remove or dissolve the blood clots and restore blood circulation. They are minimally invasive and are employed when blood starts coagulating and forms a semi-solid gel or clouts. The devices include an x-ray camera, catheter, special medications, medical device to dissolve blood clots, a radiographic table, one or two x-ray tubes, and a monitor to visualize the procedure. Other devices such as ultrasound machines and heartbeat and blood pressure monitors are also used during the procedure.

Catheter-Directed Thrombolysis Device Market Trends and Drivers:

The global catheter-directed thrombolysis devices market is primarily driven by the increasing prevalence of stroke, pulmonary embolism, and deep vein thrombosis among individuals. The rising geriatric population, which is prone to cardiovascular diseases, is also fueling the growth of the market.

In addition to this, increasing health consciousness among individuals is facilitating the early detection and treatment of cardiovascular diseases. Moreover, governing bodies are extensively investing in the healthcare sector to provide high-quality patient care and develop advanced clot management technologies, which, in turn, is propelling the market growth.

Furthermore, the availability of emergency medical services, coupled with favorable health insurance coverage, is expected to significantly impact the market in the upcoming years.

Global Catheter-Directed Thrombolysis Devices Market 2023-2028 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Catheter-Directed Thrombolysis Devices Companies:

AngioDynamics, Inc., Boston Scientific Corporation, Inari Medical, Inc., iVascular, S.L.U, Medtronic Plc, Penumbra, Inc., Straub Medical AG (Becton, Dickinson and Company), Teleflex Incorporated, Thrombolex Inc. etc.

Ask Analyst for Customization and Explore Full Report with TOC List of Figure:

The report has segmented the market on the basis of region, delivery mode, indication and end user.

Breakup by Delivery Mode:

  • Directly Delivery to Blood Clot
  • Positioning Medical Device at Clot Site

Breakup by Indication:

  • Pulmonary Embolism (PE)
  • Deep Vein Thrombosis (DVT)
  • Stroke
  • Other

Breakup by End User:

  • Hospitals
  • Others

 Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

 If you want latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

 Key highlights of the report:

  • Market Performance (2017-2022)
  • Market Outlook (2023- 2028)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Leave a Reply

Your email address will not be published. Required fields are marked *